6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.

      1 , 1 , 2 , 3 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 26 , 27 , 1
      Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
      Oxford University Press (OUP)
      DAA, HIV/HCV co-infection, IFN-free, anti-HCV therapy, antiviral therapy

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV co-infected patients participating in an Italian compassionate-use program of ombitasvir/paritaprevir/ritonavir + dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV).

          Related collections

          Author and article information

          Journal
          Clin. Infect. Dis.
          Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
          Oxford University Press (OUP)
          1537-6591
          1058-4838
          March 01 2017
          : 64
          : 5
          Affiliations
          [1 ] Clinical Infectious Diseases, Department. of Systems Medicine, Tor Vergata University, Rome, Italy.
          [2 ] Clinical Department, National Institute for Infectious Diseases, INMI "L. Spallanzani″, Rome, Italy.
          [3 ] Department of Biomedical and Clinical Science, University of Milan,Milan, Italy.
          [4 ] Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy, and School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
          [5 ] Infectious Disease Clinic, IRCCS University Hospital, San Martino IST, Genova, Italy.
          [6 ] Institute of Infectious Disease, University of Bari, Bari, Italy.
          [7 ] Division of Infectious and Tropical Diseases, IRCCS Policlinico San Matteo, Pavia, Italy.
          [8 ] Infectious Diseases Clinic, University Hospital, Modena, Italy.
          [9 ] Department of Internal and Specialty Medicine University Infectious Diseases Unit, AOU Senese, Siena, Italy.
          [10 ] Department of Infectious and Tropical Diseases, University Hospital, Padova, Italy.
          [11 ] Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
          [12 ] Department of Clinical Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
          [13 ] Clinic of Infectious and Tropical Diseases, Department of Health Sciences, University of Milan, Milan, Italy.
          [14 ] Infectious Diseases Unit, Sapienza University of Rome, Latina, Italy, and Department of Public Health and Infectious Diseases, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
          [15 ] Unit of Infectious Diseases, University of Turin, Department of Medical Sciences, "Amedeo di Savoia″ Hospital, Turin, Italy.
          [16 ] Division of Infectious Diseases, AO Papa Giovanni XXIII, Bergamo, Italy.
          [17 ] Division of Infectious Diseases, AO Niguarda Ca' Granda Hospital, Milan, Italy.
          [18 ] Division of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Brescia, Italy.
          [19 ] Division of Infectious Diseases, Department of Internal Medicine, "San Gerardo″ Hospital, University of Milan-Bicocca, Milan, Italy.
          [20 ] First Division of Infectious Diseases, S. Giovanni di Dio e Ruggi d'Aragona Hospital, Salerno, Italy.
          [21 ] Division of Infectious Diseases, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, Catania, Italy.
          [22 ] Infectious Diseases Unit, Department of Biomedical Sciences and Public Health, Marche Polytechnic University c/o Ospedali Riuniti, Ancona, Italy.
          [23 ] Infectious Disease Unit, Pescara General Hospital, Pescara, Italy.
          [24 ] Department of Public Health and Infectious Diseases, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
          [25 ] III U.O.C. P.O. Cotugno, AORN Ospedali dei Colli, Naples, Italy.
          [26 ] Clinical Infectious Diseases, Sant'Andrea Hospital - Sapienza University of Rome, Rome, Italy.
          [27 ] Unit of Infectious Diseases, University Hospital of Ferrara, Ferrara, Italy.
          Article
          ciw846
          10.1093/cid/ciw846
          28011605
          4a37557f-c58d-4715-b3fb-b42087dca12a
          History

          DAA,HIV/HCV co-infection,IFN-free,anti-HCV therapy,antiviral therapy

          Comments

          Comment on this article